⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABCL News
AbCellera Biologics Inc. Common Shares
Form 8-K
sec.gov
ABCL
VRTX
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
businesswire.com
ABCL
VRTX
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
prnewswire.com
ABCL
HYFT
SDGR
RLAY
CERT
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
prnewswire.com
ABCL
VKTX
HYFT
ABSI
NVDA
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
businesswire.com
ABCL
Form 8-K
sec.gov
ABCL
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
prnewswire.com
ABCL
HYFT
SDGR
RXRX
TEM
Form 8-K
sec.gov
ABCL
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
prnewswire.com
ABCL
JAZZ
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
businesswire.com
ABCL
JAZZ